Connect
← Return to Can anyone share their experience with Pluvicto?
Discussion
Can anyone share their experience with Pluvicto?
Prostate Cancer | Last Active: Oct 22 6:00am | Replies (79)Comment receiving replies
How much do you trust your oncologist?
He/she is just totally wrong in telling you the FDA doesn't have enough data to support it's use.
It USED to be that you had to have been treated with chemotherapy before qualifying for Pluvicto. That is no longer true. I just had my fifth Pluvicto treatment and I elected to not have chemotherapy.
There seems to be a hierarchy or tier to all the various types of cancer treatments available. A person newly diagnosed would not likely start out with Pluvicto. It's quite a ways down the line after several other, less drastic, avenues have been tried and have run their course.
It sounds like you might benefit from a second opinion from a different, more knowledgeable oncologist.
Replies to "How much do you trust your oncologist? He/she is just totally wrong in telling you the..."
Connect
Redroadtraveler,
This what is said. Norvartis Pharmaceutical completed a clinical trial (PSMA-617 Lu-177) and was approved (USFDA March 23, 2022) for one round of 6 treatments. It is now called Pluvicto. There is plenty of supporting historical and current data on the trial(s) and currect usage. After all, it was a clinical trial. It is now an approved option for metastatic castration-resistant prostate cancer. BUT, there is no data that I have found regarding REPEATING THE ENTIRE 6 ROUNDS, #7 through #12) which I just started this Sept. It was not designed for, tested or approved beyond one tound of 6 treatments. I was one of the ORIGINAL clinical trial patients 2021-2022, so I'm minutely aware of the existing data, as I am included in the findings. When rounds #7 through #12 are completed in April 2025, perhaps that new data will be released.